+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

R

Actively Recruiting

Researchers are evaluating the effectiveness of VES-0-D, an investigational wound gel, in treating mild to moderate Diabetic Foot Ulcers DFU. The study aims to compare how well VES-0-D supports wound healing compared to standard wound treatment over an 8-week period. It also investigates wound characteristics relevant to healing and monitors any side effects at the application site. Participants will receive either VES-0-D gel or standard care wound dressings applied every 3 to 4 days for up to 8 weeks or until the wound closes. Applications may be done at home or in the clinic. Weekly clinic visits will be scheduled for assessments and checkups during treatment. Throughout the study, participants will keep a diary of their wound care and any symptoms. Researchers will monitor wound area reduction and use the Bates-Jensen Wound Assessment Tool to evaluate healing progress. Safety data, including any treatment-related adverse events, will also be collected from enrollment through the end of treatment.

Age: 18Years +All GendersPhase Not Applicable
8 locations
S

Actively Recruiting

Researchers are evaluating the safety and performance of remote monitoring functions in ALIZEA, BOREA, and CELEA pacemakers for patients with bradycardia. This observational clinical investigation focuses on the devices Right Atrial Autothreshold RAAT, Right Ventricular Autothreshold RVAT, and remote alert features. The study aims to document these functions over time to better understand their reliability and safety. Participants will be included soon after pacemaker implantation and followed for 48 months. Follow-up visits occur both on-site and remotely at 1 to 3 months, 6 months, 12 months, 24 months, and 48 months after inclusion. During these visits, the remote monitoring functions and the pacing systems performance will be measured, and safety will be continuously monitored throughout the study. Throughout the study, researchers will assess cardiac pacing thresholds, technical remote alerts, and the usability of the pacemaker and remote monitoring systems. Evaluations include Right Atrial and Right Ventricular pacing thresholds at multiple timepoints up to 48 months. Participants will undergo scheduled check-ins involving measurements, monitoring, and safety assessments, with the total study duration lasting four years after enrollment.

Age: 18Years +All Genders
19 locations
C

Actively Recruiting

Researchers are studying the use of distal radial artery access compared to conventional radial artery access for complex large-bore percutaneous coronary intervention PCI in patients with complex coronary lesions such as chronic total occlusions, left main coronary artery disease, heavily calcified lesions, and complex bifurcations. This trial aims to evaluate the feasibility and safety of using a 7F Glidesheath Slender sheath for PCI via distal radial access, as prior evidence is limited and the distal radial artery may reduce radial artery occlusion risk. Participants in this randomized trial are assigned to receive PCI through either distal radial access or conventional radial access, both using the 7F Glidesheath Slender sheath Terumo Corp., Japan and a drug-eluting stent from the Ultimaster family. The study compares these two access methods for treating complex coronary lesions where a 7F guiding catheter is anticipated. The trial is multicenter, open-label, and evaluates technical and procedural success as well as vascular complications. Participants undergo PCI with one of the two access approaches, followed by assessments at hospital discharge up to day 5 including Doppler ultrasound and clinical evaluation of radial artery occlusion, bleeding, vascular complications, artery spasm, hemostasis time, pain, and hand function. Longer-term follow-up at 1 year measures hand dysfunction and target lesion failure. The study seeks to provide detailed safety and feasibility data for distal versus conventional radial artery access in complex PCI over the course of participation.

Age: 18Years +All GendersPhase Not Applicable
9 locations